Cargando…
Pericardial Involvement in Severe COVID-19 Patients
Background and Objectives: SARS-CoV-2 has an extensive tissue tropism due to its ability to attach to the surfaces of cells through different receptors, leading to systemic complications. In this article, we aim to present the prevalence of pericardial effusions in patients with severe COVID-19, to...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415465/ https://www.ncbi.nlm.nih.gov/pubmed/36013560 http://dx.doi.org/10.3390/medicina58081093 |
_version_ | 1784776238456373248 |
---|---|
author | Lazar, Mihai Barbu, Ecaterina Constanta Chitu, Cristina Emilia Anghel, Ana-Maria-Jennifer Niculae, Cristian-Mihail Manea, Eliza-Daniela Damalan, Anca-Cristina Bel, Adela-Abigaela Patrascu, Raluca-Elena Hristea, Adriana Ion, Daniela Adriana |
author_facet | Lazar, Mihai Barbu, Ecaterina Constanta Chitu, Cristina Emilia Anghel, Ana-Maria-Jennifer Niculae, Cristian-Mihail Manea, Eliza-Daniela Damalan, Anca-Cristina Bel, Adela-Abigaela Patrascu, Raluca-Elena Hristea, Adriana Ion, Daniela Adriana |
author_sort | Lazar, Mihai |
collection | PubMed |
description | Background and Objectives: SARS-CoV-2 has an extensive tissue tropism due to its ability to attach to the surfaces of cells through different receptors, leading to systemic complications. In this article, we aim to present the prevalence of pericardial effusions in patients with severe COVID-19, to identify the risk factors/predictors for pericardial involvement, and to evaluate its impact on overall mortality. Materials and Methods: We enrolled 100 patients with severe COVID-19 in our observational cohort study and divided them in two groups: Group A (27 patients with pericardial effusion) and Group B (73 patients without pericardial effusion). We recorded demographic and lifestyle parameters, anthropometric parameters, clinical parameters, inflammation markers, respiratory function parameters, complete blood count, coagulation parameters, and biochemical serum parameters. All patients were evaluated by computer tomography scans within 48 h of admission. Results: The median age was 61 years in both groups and the male/female ratio was 3.5 vs. 2.8 in Group A vs. Group B. We identified mild pericardial effusion (3–4 mm) in 62.9% patients and moderate pericardial effusion (5–9 mm) in 37.1% patients, with a median value of 4 [3;6] mm. The patients with pericardial effusion presented with higher percentages of obesity, type-2 diabetes mellitus, arterial hypertension, and congestive heart failure, without statistical significance. Increased values in cardiac enzymes (myoglobin, CK, CK-MB) and LDH were statistically associated with pericardial effusion. The overall mortality among the participants of the study was 24% (24 patients), 33.3% in Group A and 20.8% in Group B. Conclusions: Pericardial effusion has a high prevalence (27%) among patients with severe forms of COVID-19 and was associated with higher mortality. Pericardial effusion in our study was not associated with the presence of comorbidities or the extent of lung involvement. Overall mortality was 60% higher in patients with pericardial effusion. |
format | Online Article Text |
id | pubmed-9415465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94154652022-08-27 Pericardial Involvement in Severe COVID-19 Patients Lazar, Mihai Barbu, Ecaterina Constanta Chitu, Cristina Emilia Anghel, Ana-Maria-Jennifer Niculae, Cristian-Mihail Manea, Eliza-Daniela Damalan, Anca-Cristina Bel, Adela-Abigaela Patrascu, Raluca-Elena Hristea, Adriana Ion, Daniela Adriana Medicina (Kaunas) Article Background and Objectives: SARS-CoV-2 has an extensive tissue tropism due to its ability to attach to the surfaces of cells through different receptors, leading to systemic complications. In this article, we aim to present the prevalence of pericardial effusions in patients with severe COVID-19, to identify the risk factors/predictors for pericardial involvement, and to evaluate its impact on overall mortality. Materials and Methods: We enrolled 100 patients with severe COVID-19 in our observational cohort study and divided them in two groups: Group A (27 patients with pericardial effusion) and Group B (73 patients without pericardial effusion). We recorded demographic and lifestyle parameters, anthropometric parameters, clinical parameters, inflammation markers, respiratory function parameters, complete blood count, coagulation parameters, and biochemical serum parameters. All patients were evaluated by computer tomography scans within 48 h of admission. Results: The median age was 61 years in both groups and the male/female ratio was 3.5 vs. 2.8 in Group A vs. Group B. We identified mild pericardial effusion (3–4 mm) in 62.9% patients and moderate pericardial effusion (5–9 mm) in 37.1% patients, with a median value of 4 [3;6] mm. The patients with pericardial effusion presented with higher percentages of obesity, type-2 diabetes mellitus, arterial hypertension, and congestive heart failure, without statistical significance. Increased values in cardiac enzymes (myoglobin, CK, CK-MB) and LDH were statistically associated with pericardial effusion. The overall mortality among the participants of the study was 24% (24 patients), 33.3% in Group A and 20.8% in Group B. Conclusions: Pericardial effusion has a high prevalence (27%) among patients with severe forms of COVID-19 and was associated with higher mortality. Pericardial effusion in our study was not associated with the presence of comorbidities or the extent of lung involvement. Overall mortality was 60% higher in patients with pericardial effusion. MDPI 2022-08-12 /pmc/articles/PMC9415465/ /pubmed/36013560 http://dx.doi.org/10.3390/medicina58081093 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lazar, Mihai Barbu, Ecaterina Constanta Chitu, Cristina Emilia Anghel, Ana-Maria-Jennifer Niculae, Cristian-Mihail Manea, Eliza-Daniela Damalan, Anca-Cristina Bel, Adela-Abigaela Patrascu, Raluca-Elena Hristea, Adriana Ion, Daniela Adriana Pericardial Involvement in Severe COVID-19 Patients |
title | Pericardial Involvement in Severe COVID-19 Patients |
title_full | Pericardial Involvement in Severe COVID-19 Patients |
title_fullStr | Pericardial Involvement in Severe COVID-19 Patients |
title_full_unstemmed | Pericardial Involvement in Severe COVID-19 Patients |
title_short | Pericardial Involvement in Severe COVID-19 Patients |
title_sort | pericardial involvement in severe covid-19 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415465/ https://www.ncbi.nlm.nih.gov/pubmed/36013560 http://dx.doi.org/10.3390/medicina58081093 |
work_keys_str_mv | AT lazarmihai pericardialinvolvementinseverecovid19patients AT barbuecaterinaconstanta pericardialinvolvementinseverecovid19patients AT chitucristinaemilia pericardialinvolvementinseverecovid19patients AT anghelanamariajennifer pericardialinvolvementinseverecovid19patients AT niculaecristianmihail pericardialinvolvementinseverecovid19patients AT maneaelizadaniela pericardialinvolvementinseverecovid19patients AT damalanancacristina pericardialinvolvementinseverecovid19patients AT beladelaabigaela pericardialinvolvementinseverecovid19patients AT patrascuralucaelena pericardialinvolvementinseverecovid19patients AT hristeaadriana pericardialinvolvementinseverecovid19patients AT iondanielaadriana pericardialinvolvementinseverecovid19patients |